blogs

Careers

clients

Case Studies

Offices

About Us

pages

people

posts

staffs

testimonials

Home - Whistleblower Attorneys

core/heading

Mylan Inc. (MYL), the generic-drug company, agreed to pay $57 million to settle claims it caused the U.S. and California to overpay for drugs.

core/paragraph

The settlement, filed yesterday in federal court in Boston, came in cases filed by Ven-A-Care of the Florida Keys Inc., a specialty pharmacy. California will get $26.3 million, the U.S. will get $22.2 million, and Ven-A-Care and its attorneys will get $8.5 million, court records show.

To read the complete article, click here.

core/button

core/buttons

Mylan to Pay $57 Million to Settle Drug Overpricing Claims

News